PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Evidence grows that melanoma drugs benefit some lung cancer patients

Many patients with BRAF-mutant cancers benefit from treatment with BRAF inhibitors, European researchers report at ELCC

2015-04-17
(Press-News.org) Geneva, Switzerland, 17 April 2015 -- A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to treat melanoma, the authors of a new academic clinical trial in Europe have reported at the European Lung Cancer Conference (ELCC) in Geneva, Switzerland.

Dr. Oliver Gautschi, a medical oncologist from Lucern Cantonal Hospital in Switzerland, presented the results of the retrospective EURAF cohort study, which included lung cancer patients whose tumours carried specific mutations in the BRAF gene. The study was conducted by a network of European oncologists, without company involvement.

BRAF mutations are commonly seen in melanoma patients, and are found in about 2% of lung adenocarcinomas, Gautschi explains. Several inhibitors of the B-Raf protein, including vemurafenib and dabrafenib, have been developed for use in melanoma patients, however there is currently no approved drug for BRAF-mutant lung cancer.

As a result, experience with B-Raf inhibitors in lung cancer remains limited. "In the current study, we wanted to find out how many patients in Europe received B-Raf inhibitors outside of a clinical trial, and what their outcomes were," Gautschi says.

The EURAF study gathered information on 35 lung cancer patients who had been identified as carrying BRAF mutations, who were treated with B-Raf inhibitors between 2012 and 2014. Most of those patients received vemurafenib, some dabrafenib, and one sorafenib. Overall response rate was 53% as measured by the widely used Response Evaluation Criteria In Solid Tumors (RECIST) guidelines. Overall, progression-free survival time in this group was 5 months. Most patients were pretreated, and not eligible for enrolment in a clinical trial, which means these results are encouraging, the researchers say, although the study's small size and retrospective nature mean the analysis of the magnitude of benefit should be treated cautiously.

"The bottom line is that clinicians should be sure to test patients for so-called 'rare' driver mutations in lung cancer, because individual patients may derive substantial benefit from targeted therapy," says Gautschi.

Commenting on the findings, Dr David Planchard, pulmonary oncologist at Gustave Roussy in Villejuif, France, said that the results of the trial confirm the benefit of B-Raf inhibitors in BRAF-mutant non-small cell lung cancer. The current trial also confirmed the good tolerance of the drugs with no new side-effects, he said. Planchard and colleagues have presented a separate phase II study in this area with dabrafenib [1].

"This trial is important because due to the low frequency of this mutation in non-small cell lung cancer we will have few trials on this population," Planchard commented. "The more data we have, the better we understand how important it is to test for the mutation, especially in adenocarcinomas, and to expose mutation-positive patients to a specific B-Raf inhibitor."

The results also add to growing support for the approval of B-Raf inhibitors for use in lung cancer, Planchard added. This is important because the rarity of this mutation means that performing the kind of randomized phase III trials usually required for licensing approval will be extremely difficult, he noted.

Looking ahead, it will also be important to see results of combination therapy with inhibitors of B-Raf and a related protein, Mek, in non-small cell lung cancer carrying BRAF-V600E mutations, the researchers note, as this combination has shown a higher clinical benefit in BRAF-mutant melanoma.

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Professional golfers live a lonely life in the midst of rivalries on a meager income

2015-04-17
Many professional golfers live a lonely isolated life in the midst of intense rivalries and on a meagre income, new research shows. Dr John Fry told the British Sociological Association's annual conference in Glasgow today [Friday 17 April] that he interviewed 20 professionals, including Ryder Cup players and a former world number one, to reveal the "particular stresses" behind the glamour of the game. Dr Fry, of Myerscough College, said that the number of tournaments held abroad had increased over recent years. "The impact of the increasingly global nature of professional ...

Expanding rubber plantations 'catastrophic' for endangered species in Southeast Asia

Expanding rubber plantations catastrophic for endangered species in Southeast Asia
2015-04-17
Demand for natural rubber fuelled by the tyre industry is threatening protected parts of Southeast Asia - according to research from the University of East Anglia (UEA). A new study published today predicts that up to 8.5 million hectares of additional rubber plantations will be required to meet demand by 2024. But expansion on this scale will have 'catastrophic' biodiversity impacts, with globally threatened unique species and ecosystems all put under threat. Researchers say that the extent of the problem is comparable to oil palm and that it is closely linked ...

9/11 leaves legacy of chronic ill health among emergency medical services workers

2015-04-17
The 9/11 attacks on the World Trade Center in New York City in 2001 have left a legacy of chronic ill health among emergency medical services workers who came to the rescue of the victims, reveals research published online in Occupational & Environmental Medicine. Those who arrived in the immediate aftermath of the attacks are most at risk of physical and mental ailments, the findings show. The health of 2281 New York City Fire Department emergency medical services workers deployed to the scene of the World Trade Center attacks was tracked over a period of 12 years, ...

Local physician recommends World Health Organization retire the term opioid substitution therapy

2015-04-17
(Boston)--A Boston researcher and physician caring for individuals with substance abuse disorders, believes the term opioid substitution therapy (OST) has unintended adverse consequences for patients receiving treatment for addiction. In a correspondence to the editors of the journal Lancet, Jeffrey H. Samet, MD, MA, MPH, professor of medicine at Boston University School of Medicine (BUSM) and chief of the section of General Internal Medicine at Boston Medical Center maintains that the use of the non-medical term OST serves to reinforce the concept that this type of treatment ...

The Lancet Neurology: Autism Series media alert

2015-04-17
The Lancet Neurology journal is pleased to announce that the following papers will be published as part of a Series on autism spectrum disorder, ahead of the 2015 Annual Meeting of the American Academy of Neurology: Gene hunting in autism spectrum disorder: on the path to precision medicine [Embargo: 6:30pm [New York time] Thursday 16 April, 2015] Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan [Embargo: 6:30pm [New York time] Thursday 16 April, 2015] Gene hunting in autism spectrum disorder: on the path to precision medicine ...

Family history increases the risk of cardiac arrest in patients on dialysis

2015-04-17
Highlights Among dialysis patients, genetically related family members have about a 70% increased risk of cardiac arrest compared with unrelated dialysis patients. Spouses on dialysis do not have an increased risk. Cardiac arrest is the #1 cause of death in patients on dialysis. Washington, DC (April 16, 2015) -- The increased risk of cardiac arrest experienced by patients with kidney failure may, in part, be inherited, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Uncovering the genes that are ...

Playing a wind instrument could help lower the risk of sleep apnea

2015-04-17
A new study has found that wind instrument players have a reduced risk of developing obstructive sleep apnoea. The findings, presented today (17 April 2015) at the Sleep and Breathing Conference 2015, suggest that this could be considered beneficial to those individuals who are at high risk of developing sleep apnoea. Researchers in India conducted lung function testing in 64 people who played a wind instrument and compared results to a control group of 65 people who did not play any wind instruments. All participants also completed the Berlin questionnaire, an established ...

Cancer-related PTS linked to very limited cognitive impairment among newly diagnosed breast cancer patients

2015-04-16
Cancer-related post-traumatic stress is associated with very limited cognitive impairment before treatment among newly diagnosed breast cancer patients, according to a new study published April 16 in the JNCI: Journal of the National Cancer Institute. Pretreatment cognitive impairment and symptoms of post-traumatic stress disorder have been independently reported among cancer patients. Post-traumatic stress has also been linked to cognitive impairment. However, a clear relationship between post-traumatic stress in the setting of a cancer diagnosis and cognitive impairment ...

Epilepsy drug may preserve eyesight for people with MS

2015-04-16
WASHINGTON, DC - A drug commonly taken to prevent seizures in epilepsy may surprisingly protect the eyesight of people with multiple sclerosis (MS), according to a study released today that will be presented at the American Academy of Neurology's 67th Annual Meeting in Washington, DC, April 18 to 25, 2015. "About half of people with MS experience at some point in their life a condition called acute optic neuritis, in which the nerve carrying vision from the eye to the brain gets inflamed," said study author Raj Kapoor, MD, with the National Hospital for Neurology and ...

Smokers who use e-cigarettes less likely to quit

2015-04-16
The rapid increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation tool. A study, published online on April 16 in the American Journal of Public Health, suggests proponents are in error. University of California, San Diego School of Medicine researchers found that smokers who used e-cigarettes were 49 percent less likely to decrease cigarette use and 59 percent less likely to quit smoking compared to smokers who never used e-cigarettes. ...

LAST 30 PRESS RELEASES:

Eindhoven University of Technology and JMIR Publications announce unlimited open access publishing agreement

Orphan nuclear receptors in metabolic dysfunction-associated steatotic liver disease development

A technological breakthrough for ultra-fast and greener AI

Pusan National University researchers identify key barriers hindering data-driven smart manufacturing adoption

Inking heterometallic nanosheets: A scalable breakthrough for coating, electronics, and electrocatalyst applications

Adults with autism show similar brain mapping of body parts as typically developing adults

Uncovering behavioral clues to childhood maltreatment

Premenstrual symptoms linked to increased risk of cardiovascular disease

Newly discovered remains of ancient river landscapes control ice flow in East Antarctica

Newly discovered interstellar object 'may be oldest comet ever seen'

Animal-inspired AI robot learns to navigate unfamiliar terrain

Underserved youth less likely to visit emergency department for concussion in Ontario, study finds

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂

Groundbreaking quantum study puts wave-particle duality to work

Weekly injection could be life changing for Parkinson’s patients

Toxic metals linked to impaired growth in infants in Guatemala

Being consistently physically active in adulthood linked to 30–40% lower risk of death

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Children’s social care involvement common to nearly third of UK mums who died during perinatal period

‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths

Ethnic minority and poorer children more likely to die in intensive care

Major progress in fertility preservation after treatment for cancer of the lymphatic system

Fewer complications after additional ultrasound in pregnant women who feel less fetal movement

Environmental impact of common pesticides seriously underestimated

The Milky Way could be teeming with more satellite galaxies than previously thought

New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly

Media Tip Sheet: Symposia at ESA2025

NSF CAREER Award will power UVA engineer’s research to improve drug purification

Tiny parasitoid flies show how early-life competition shapes adult success

[Press-News.org] Evidence grows that melanoma drugs benefit some lung cancer patients
Many patients with BRAF-mutant cancers benefit from treatment with BRAF inhibitors, European researchers report at ELCC